HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hui Wang Selected Research

Guanine Nucleotide Dissociation Inhibitors (GDIs)

1/2014Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
1/2013Loss of RhoGDI is a novel independent prognostic factor in hepatocellular carcinoma.
9/2008Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hui Wang Research Topics

Disease

937Neoplasms (Cancer)
12/2022 - 01/2002
246Infections
12/2022 - 11/2002
163Neoplasm Metastasis (Metastasis)
12/2022 - 03/2004
142Inflammation (Inflammations)
11/2022 - 03/2005
131Breast Neoplasms (Breast Cancer)
05/2022 - 05/2002
95Hepatocellular Carcinoma (Hepatoma)
06/2022 - 04/2003
81Fibrosis (Cirrhosis)
07/2022 - 05/2004
79Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 03/2003
75Carcinogenesis
10/2022 - 05/2002
71Lung Neoplasms (Lung Cancer)
06/2022 - 02/2002
69COVID-19
12/2022 - 01/2020
67Body Weight (Weight, Body)
05/2022 - 05/2004
65Hypoxia (Hypoxemia)
05/2022 - 09/2003
56Type 2 Diabetes Mellitus (MODY)
11/2022 - 11/2007
55Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 06/2006
52Stomach Neoplasms (Stomach Cancer)
02/2022 - 04/2006
50Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022 - 09/2005
49Insulin Resistance
06/2022 - 11/2006
48Wounds and Injuries (Trauma)
05/2022 - 08/2004
48Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2003
48Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2022 - 11/2005
47Prostatic Neoplasms (Prostate Cancer)
12/2022 - 02/2003
43Ovarian Neoplasms (Ovarian Cancer)
07/2022 - 02/2007
43Carcinoma (Carcinomatosis)
03/2022 - 09/2003
41Obesity
01/2022 - 10/2006
40Hypertension (High Blood Pressure)
10/2022 - 06/2003
39Pain (Aches)
06/2022 - 02/2013
39Sepsis (Septicemia)
03/2022 - 01/2006
38Glioma (Gliomas)
01/2022 - 03/2004
37Necrosis
01/2022 - 10/2003
35Nasopharyngeal Carcinoma
09/2022 - 01/2012
35Osteoarthritis
07/2022 - 09/2009
34Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 09/2006
33Ischemia
01/2022 - 09/2003
31Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 11/2010
31Chronic Hepatitis B
01/2022 - 11/2003
31Virus Diseases (Viral Diseases)
01/2022 - 12/2009
31Leukemia
06/2021 - 03/2004
30Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 04/2007
30Atherosclerosis
05/2022 - 08/2007
30Hemorrhage
05/2022 - 03/2007
30Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 02/2006
29Lymphatic Metastasis
07/2022 - 01/2004
29Hypersensitivity (Allergy)
01/2022 - 03/2003
29Myocardial Infarction
01/2022 - 01/2007
27Pneumonia (Pneumonitis)
03/2022 - 01/2006
26Disease Progression
03/2022 - 05/2013
26Liver Neoplasms (Liver Cancer)
01/2022 - 01/2011
25Reperfusion Injury
04/2022 - 10/2003
24Adenocarcinoma
01/2022 - 05/2003

Drug/Important Bio-Agent (IBA)

368Proteins (Proteins, Gene)FDA Link
12/2022 - 05/2002
166Pharmaceutical PreparationsIBA
12/2022 - 04/2002
163Biomarkers (Surrogate Marker)IBA
06/2022 - 11/2004
121Messenger RNA (mRNA)IBA
08/2022 - 05/2002
95CytokinesIBA
08/2022 - 11/2005
93Glucose (Dextrose)FDA LinkGeneric
06/2022 - 08/2007
93MicroRNAs (MicroRNA)IBA
05/2022 - 08/2009
85Biological ProductsIBA
10/2022 - 04/2003
83DNA (Deoxyribonucleic Acid)IBA
10/2022 - 05/2002
70Therapeutic UsesIBA
03/2022 - 04/2002
67LipidsIBA
12/2022 - 01/2006
65EnzymesIBA
11/2022 - 12/2003
60Long Noncoding RNAIBA
10/2022 - 01/2016
57RNA (Ribonucleic Acid)IBA
12/2022 - 07/2004
51Peptides (Polypeptides)IBA
03/2022 - 01/2005
51AntigensIBA
01/2022 - 04/2002
47VaccinesIBA
06/2022 - 03/2003
43Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 01/2006
42Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 07/2004
40Interleukin-6 (Interleukin 6)IBA
03/2022 - 01/2003
39Small Interfering RNA (siRNA)IBA
12/2022 - 11/2005
39LigandsIBA
08/2022 - 04/2003
39CholesterolIBA
07/2022 - 01/2007
39CollagenIBA
07/2022 - 11/2004
37Insulin (Novolin)FDA Link
03/2022 - 08/2007
37Antiviral Agents (Antivirals)IBA
01/2022 - 07/2005
36Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022 - 03/2012
34Dexamethasone (Maxidex)FDA LinkGeneric
06/2022 - 03/2004
33Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2022 - 01/2004
33Caffeine (No Doz)FDA LinkGeneric
07/2022 - 01/2012
30Indicators and Reagents (Reagents)IBA
09/2022 - 12/2004
30GlucocorticoidsIBA
07/2022 - 11/2007
29Phosphotransferases (Kinase)IBA
08/2022 - 05/2002
29AntioxidantsIBA
03/2022 - 12/2003
28AntibodiesIBA
12/2022 - 05/2003
27Transcription Factors (Transcription Factor)IBA
11/2022 - 01/2005
27Blood Glucose (Blood Sugar)IBA
03/2022 - 01/2011
27Cisplatin (Platino)FDA LinkGeneric
01/2022 - 02/2002
25Amyloid (Amyloid Fibrils)IBA
05/2022 - 01/2003
24LipopolysaccharidesIBA
08/2022 - 02/2008
24Oxygen (Dioxygen)IBA
04/2022 - 01/2006

Therapy/Procedure

451Therapeutics
12/2022 - 01/2002
122Drug Therapy (Chemotherapy)
07/2022 - 09/2003
89Radiotherapy
09/2022 - 12/2003
58Immunotherapy
07/2022 - 03/2003
41Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2022 - 01/2008
28Transplantation
12/2022 - 01/2007
28Aftercare (After-Treatment)
01/2022 - 03/2004
26Neoadjuvant Therapy
01/2022 - 10/2012
25Ligation
09/2021 - 01/2005